Wolfgang Hackl

Founder and Managing Director at OncoGenomX Inc. PredictionStar of OncoGenomX Inc is an innovative aid for Breast Cancer physicians and patients, deserving optimal therapy. PredictionStar is the first of its kind point-of-care technology platform, amenable to any molecular cancer diagnostics laboratory. The technology works by using patented algorithms for analysis of tumor-specific genomic, biological, pathological, and patient-specific clinical information, complemented by intelligence-augmented drug – tumor matching, calibration with real-world outcome data to guide evidence-based therapy decisions.